KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Debt to Equity (2016 - 2020)

Neogenomics' Debt to Equity history spans 11 years, with the latest figure at $0.19 for Q1 2020.

  • For Q1 2020, Debt to Equity fell 34.69% year-over-year to $0.19; the TTM value through Mar 2020 reached $0.19, down 34.69%, while the annual FY2019 figure was $0.19, 375.03% up from the prior year.
  • Debt to Equity reached $0.19 in Q1 2020 per NEO's latest filing, down from $0.19 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.46 in Q4 2016 to a low of $0.01 in Q2 2019.
  • Average Debt to Equity over 5 years is $0.23, with a median of $0.22 recorded in 2018.
  • The largest YoY upside for Debt to Equity was 740.18% in 2019 against a maximum downside of 95.31% in 2019.
  • A 5-year view of Debt to Equity shows it stood at $0.46 in 2016, then decreased by 10.12% to $0.41 in 2017, then plummeted by 90.18% to $0.04 in 2018, then soared by 375.03% to $0.19 in 2019, then decreased by 0.8% to $0.19 in 2020.
  • Per Business Quant, the three most recent readings for NEO's Debt to Equity are $0.19 (Q1 2020), $0.19 (Q4 2019), and $0.2 (Q3 2019).